C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
195/1.13, 150/8.
C12Q 1/70 (2006.01) A61K 39/12 (2006.01) C07H 21/00 (2006.01) C12N 15/11 (2006.01) G01N 33/569 (2006.01)
Patent
CA 1341088
Inhibition of HTLV-III by administration of an oligonucleotide complementary to highly conserved regions of the HTLV-III genome necessary for HTLV-III replication and/or gene expression is described, as are oligodeoxynucleotide sequences which are complementary to those regions, methods of inhibiting HTLV-III replication and gene expression and methods of determining the presence or absence of HTLV-III virus in samples such as blood, saliva, urine and tears.
537839
Goodchild John
Zamecnik Paul C.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
University Of Massachusetts
Worcester Foundation For Experimental Biology Inc.
LandOfFree
Inhibition of htlv-iii by exogenous oligonucleotides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of htlv-iii by exogenous oligonucleotides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of htlv-iii by exogenous oligonucleotides will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1243433